RecruitingNCT06341517
Active or sham cerebellar stimulation for apathy in schizophrenia
About this title
Read the official source — NCT06341517Device studyAges 18–65Switzerland
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Geneva and 1 more locationSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 15, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 70
- Sponsor
- Indrit Begue
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Locations
- Switzerland
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06341517
- Official title
Show the full official title
Brain Circuitry Therapeutics for Schizophrenia - A Cross-species Longitudinal Randomized Controlled Clinical Study to Treat Negative Symptoms of Schizophrenia Using Non-invasive Stimulation of the Cerebellum
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Geneva
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Indrit Begue.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
